{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:16:09Z","timestamp":1786979769563,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00210-026-04987-6","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T01:37:01Z","timestamp":1769564221000},"page":"9881-9892","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u03b2-Carboline alkaloid harmaline alleviates hyperuricemia-mediated renal inflammation by suppressing oxidative stress"],"prefix":"10.1007","volume":"399","author":[{"given":"Ayush","family":"Kattna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2903-4293","authenticated-orcid":false,"given":"Lovedeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Nazam","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz S.","family":"Saeedan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Abdulrahman","family":"Aldossary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"4987_CR1","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.jad.2013.08.032","volume":"151","author":"V Arora","year":"2013","unstructured":"Arora V, Chopra K (2013) Possible involvement of oxido-nitrosative stress-induced neuro-inflammatory cascade and monoaminergic pathway: underpinning the correlation between nociceptive and depressive behaviour in a rodent model. J Affect Disord 151:1041\u20131052. https:\/\/doi.org\/10.1016\/j.jad.2013.08.032","journal-title":"J Affect Disord"},{"issue":"1","key":"4987_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.13005\/bpj\/2106","volume":"14","author":"DM Beltagy","year":"2021","unstructured":"Beltagy DM, GamalAbdelsalam K, Mohamed TM, El-Keey MM (2021) Role of harmaline as an adiponectin modulator in defeating liver cirrhosis induced by thioacetamide in mice. Biomed Pharmacol J 14(1):123\u2013134. https:\/\/doi.org\/10.13005\/bpj\/2106","journal-title":"Biomed Pharmacol J"},{"key":"4987_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1053\/j.ackd.2012.07.009","volume":"19","author":"IA Bobulescu","year":"2012","unstructured":"Bobulescu IA, Moe OW (2012) Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis 19:358\u2013371. https:\/\/doi.org\/10.1053\/j.ackd.2012.07.009","journal-title":"Adv Chronic Kidney Dis"},{"key":"4987_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04220-w","author":"S Chaubey","year":"2025","unstructured":"Chaubey S, Singh L (2025) Harmaline attenuates pain and inflammation: role of IL-1\u03b2, oxidative stress, nitric oxide, and cyclooxygenase. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04220-w","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"4987_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57010058","volume":"57","author":"AFG Cicero","year":"2021","unstructured":"Cicero AFG, Fogacci F, Kuwabara M, Borghi C (2021) Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update. Medicina 57(1):58. https:\/\/doi.org\/10.3390\/medicina57010058","journal-title":"Medicina"},{"key":"4987_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/535686","volume":"2015","author":"M Crist\u00f3bal-Garc\u00eda","year":"2015","unstructured":"Crist\u00f3bal-Garc\u00eda M, Garc\u00eda-Arroyo FE, Tapia E, Osorio H, Arellano-Buend\u00eda AS, Madero M, Rodr\u00edguez-Iturbe B, Pedraza-Chaverr\u00ed J, Correa F, Zazueta C, Johnson RJ (2015) Renal oxidative stress induced by long-term hyperuricemia alters mitochondrial function and maintains systemic hypertension. Oxid Med Cell Longev 2015:535686. https:\/\/doi.org\/10.1155\/2015\/535686","journal-title":"Oxid Med Cell Longev"},{"key":"4987_CR7","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1152\/ajprenal.00121.2024","volume":"327","author":"LV Dissanayake","year":"2024","unstructured":"Dissanayake LV, Palygin O (2024) Is there a role for uric acid in polycystic kidney disease progression? Am J Physiol Renal Physiol 327:F1\u2013F3. https:\/\/doi.org\/10.1152\/ajprenal.00121.2024","journal-title":"Am J Physiol Renal Physiol"},{"key":"4987_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"M Francis","year":"2024","unstructured":"Francis M, Harhay MN, Ong AC, Tummalapalli SL, Ortiz A, Fogo AB (2024) Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol 20:473\u2013485. https:\/\/doi.org\/10.1038\/s41581-024-00820-6","journal-title":"Nat Rev Nephrol"},{"key":"4987_CR9","doi-asserted-by":"publisher","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","volume":"319","author":"M Furuhashi","year":"2020","unstructured":"Furuhashi M (2020) New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab 319:E827\u2013E834. https:\/\/doi.org\/10.1152\/ajpendo.00378.2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4987_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5478708","volume":"2020","author":"M Gyur\u00e1szov\u00e1","year":"2020","unstructured":"Gyur\u00e1szov\u00e1 M, Gureck\u00e1 R, B\u00e1b\u00ed\u010dkov\u00e1 J, T\u00f3thov\u00e1 \u013d (2020) Oxidative stress in the pathophysiology of kidney disease: implications for noninvasive monitoring and identification of biomarkers. Oxid Med Cell Longev 2020:5478708. https:\/\/doi.org\/10.1155\/2020\/5478708","journal-title":"Oxid Med Cell Longev"},{"key":"4987_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1402369","volume":"15","author":"Y He","year":"2024","unstructured":"He Y, Chen X, Ma Z, Wang J, Lin K (2024) Association of oxidative balance score with hyperuricemia and gout: NHANES 2009\u20132018. Front Endocrinol 15:1402369. https:\/\/doi.org\/10.3389\/fendo.2024.1402369","journal-title":"Front Endocrinol"},{"issue":"29","key":"4987_CR12","doi-asserted-by":"publisher","first-page":"9143","DOI":"10.1021\/acs.jafc.2c03187","volume":"70","author":"T Herraiz","year":"2022","unstructured":"Herraiz T, Pe\u00f1a A, Mateo H, Herraiz M, Salgado A (2022) Formation, characterization, and occurrence of \u03b2-carboline alkaloids derived from \u03b1-dicarbonyl compounds and L-tryptophan. J Agric Food Chem 70(29):9143\u20139153. https:\/\/doi.org\/10.1021\/acs.jafc.2c03187","journal-title":"J Agric Food Chem"},{"key":"4987_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L (2023) Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther 8:129. https:\/\/doi.org\/10.1038\/s41392-023-01379-7","journal-title":"Signal Transduct Target Ther"},{"key":"4987_CR14","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1016\/S2214-109X(24)0005-0","volume":"12","author":"M Jadoul","year":"2024","unstructured":"Jadoul M, Aoun M, Imani MM (2024) The major global burden of chronic kidney disease. Lancet Glob Health 12:e342\u2013e343. https:\/\/doi.org\/10.1016\/S2214-109X(24)0005-0","journal-title":"Lancet Glob Health"},{"key":"4987_CR15","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1021\/acsomega.9b02375","volume":"5","author":"S Jain","year":"2020","unstructured":"Jain S, Panuganti V, Jha S, Roy I (2020) Harmine acts as an indirect inhibitor of intracellular protein aggregation. ACS Omega 5:5620\u20135628. https:\/\/doi.org\/10.1021\/acsomega.9b02375","journal-title":"ACS Omega"},{"key":"4987_CR16","doi-asserted-by":"publisher","unstructured":"James MT, Chawla LS, Kimmel PL (2020) Acute kidney injury and chronic kidney disease. Chronic Renal Dis 397\u2013409. https:\/\/doi.org\/10.1016\/B978-0-12-815876-0.00026-7","DOI":"10.1016\/B978-0-12-815876-0.00026-7"},{"key":"4987_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ekir.2022.11.016","volume":"8","author":"RJ Johnson","year":"2023","unstructured":"Johnson RJ, Lozada LG, Lanaspa MA, Piani F, Borghi C (2023) Uric acid and chronic kidney disease: still more to do. Kidney Int Rep 8:229\u2013239. https:\/\/doi.org\/10.1016\/j.ekir.2022.11.016","journal-title":"Kidney Int Rep"},{"key":"4987_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2024.138003","volume":"842","author":"P Kadyan","year":"2024","unstructured":"Kadyan P, Singh L (2024) Harmaline attenuates chemotherapy-induced peripheral neuropathy: modulation of Nrf-2 pathway and NK-1 receptor signaling. Neurosci Lett 842:138003. https:\/\/doi.org\/10.1016\/j.neulet.2024.138003","journal-title":"Neurosci Lett"},{"issue":"5","key":"4987_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10787-014-0215-y","volume":"22","author":"M Kaur","year":"2014","unstructured":"Kaur M, Bedi O, Sachdeva S, Reddy BK, Kumar P (2014) Rodent animal models: from mild to advanced stages of diabetic nephropathy. Inflammopharmacology 22(5):279\u2013293. https:\/\/doi.org\/10.1007\/s10787-014-0215-y","journal-title":"Inflammopharmacology"},{"issue":"1","key":"4987_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40200-015-0185-7","volume":"14","author":"M Kaur","year":"2015","unstructured":"Kaur M, Sachdeva S, Bedi O, Kaur T, Kumar P (2015) Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats. J Diabetes Metab Disord 14(1):63. https:\/\/doi.org\/10.1186\/s40200-015-0185-7","journal-title":"J Diabetes Metab Disord"},{"key":"4987_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP (2022) Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl 12:7\u201311. https:\/\/doi.org\/10.1016\/j.kisu.2021.11.003","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"4987_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40200-017-0331-5","volume":"16","author":"P Krishan","year":"2017","unstructured":"Krishan P, Singh G, Bedi O (2017) Carbohydrate restriction ameliorates nephropathy by reducing oxidative stress and upregulating HIF-1\u03b1 levels in type 1 diabetic rats. J Diabetes Metab Disord 16(1):47. https:\/\/doi.org\/10.1186\/s40200-017-0331-5","journal-title":"J Diabetes Metab Disord"},{"issue":"2","key":"4987_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1046\/j.1471-4159.2000.0750521.x","volume":"75","author":"CS Lee","year":"2000","unstructured":"Lee CS, Han ES, Jang YY, Han JH, Ha HW, Kim DE (2000) Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells. J Neurochem 75(2):521\u2013531. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0750521.x","journal-title":"J Neurochem"},{"key":"4987_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00346","volume":"9","author":"SP Li","year":"2018","unstructured":"Li SP, Wang YW, Qi SL, Zhang YP, Deng G, Ding WZ, Ma C, Lin QY, Guan HD, Liu W, Cheng XM (2018) Analogous \u03b2-carboline alkaloids harmaline and harmine ameliorate scopolamine-induced cognitive dysfunction by attenuating acetylcholinesterase activity, oxidative stress, and inflammation in mice. Front Pharmacol 9:346. https:\/\/doi.org\/10.3389\/fphar.2018.00346","journal-title":"Front Pharmacol"},{"issue":"7","key":"4987_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.101183","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Lin Z, Jin H, Wei F, Ma S, Zhang B (2025) The anti-hyperuricemia potential of bioactive natural products and extracts derived from traditional Chinese medicines: a review and perspective. J Pharm Anal 15(7):101183. https:\/\/doi.org\/10.1016\/j.jpha.2024.101183","journal-title":"J Pharm Anal"},{"key":"4987_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.08.031","volume":"22","author":"Z Li","year":"2025","unstructured":"Li Z, Su Y, Su H, Pan J, Li S, Lu L, Ji G, Xu H (2025) Serum uric acid and its metabolism: a vital factor in the inflammatory transformation of cancer. J Adv Res 22:S2090-1232(25)00646-0. https:\/\/doi.org\/10.1016\/j.jare.2025.08.031","journal-title":"J Adv Res"},{"key":"4987_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1470380","volume":"2021","author":"N Liu","year":"2021","unstructured":"Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H, Jiang J, Xu Y, Lu W (2021) The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors. Oxid Med Cell Longev 2021:1470380. https:\/\/doi.org\/10.1155\/2021\/1470380","journal-title":"Oxid Med Cell Longev"},{"key":"4987_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","volume":"820","author":"W Lv","year":"2018","unstructured":"Lv W, Booz GW, Wang Y, Fan F, Roman RJ (2018) Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol 820:65\u201376. https:\/\/doi.org\/10.1016\/j.ejphar.2017.12.016","journal-title":"Eur J Pharmacol"},{"key":"4987_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-016-0684-z","volume":"18","author":"SG Mallat","year":"2016","unstructured":"Mallat SG, Al Kattar S, Tanios BY, Jurjus A (2016) Hyperuricemia, hypertension, and chronic kidney disease: an emerging association. Curr Hypertens Rep 18:74. https:\/\/doi.org\/10.1007\/s11906-016-0684-z","journal-title":"Curr Hypertens Rep"},{"key":"4987_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.clicom.2022.03.003","volume":"2","author":"PR Nunes","year":"2022","unstructured":"Nunes PR, Romao-Veiga M, Peracoli MT, Peracoli JC, Sandrim VC (2022) Potential role of uric acid to activate NLRP3 inflammasome triggering endothelial dysfunction in preeclampsia. Clin Immunol 2:69\u201375. https:\/\/doi.org\/10.1016\/j.clicom.2022.03.003","journal-title":"Clin Immunol"},{"key":"4987_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41581-021-00462-y","volume":"17","author":"M Oshima","year":"2021","unstructured":"Oshima M, Shimizu M, Yamanouchi M, Toyama T, Hara A, Furuichi K (2021) Trajectories of kidney function in diabetes: a clinicopathological update. Nat Rev Nephrol 17:740\u2013750. https:\/\/doi.org\/10.1038\/s41581-021-00462-y","journal-title":"Nat Rev Nephrol"},{"key":"4987_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315\u2013424. https:\/\/doi.org\/10.1152\/physrev.00029.2006","journal-title":"Physiol Rev"},{"issue":"1","key":"4987_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/13880209.2017.1421235","volume":"56","author":"VH Sato","year":"2018","unstructured":"Sato VH, Sungthong B, Rinthong PO, Nuamnaichati N, Mangmool S, Chewchida S, Sato H (2018) Pharmacological effects of chatuphalatika in hyperuricemia of gout. Pharm Biol 56(1):76\u201385. https:\/\/doi.org\/10.1080\/13880209.2017.1421235","journal-title":"Pharm Biol"},{"key":"4987_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1306-1","volume":"20","author":"M Seki","year":"2019","unstructured":"Seki M, Nakayama M, Sakoh T, Yoshitomi R, Fukui A, Katafuchi E, Tsuda S, Nakano T, Tsuruya K, Kitazono T (2019) Blood urea nitrogen is independently associated with renal outcomes in Japanese patients with stage 3-5 chronic kidney disease: a prospective observational study. BMC Nephrol 20:115. https:\/\/doi.org\/10.1186\/s12882-019-1306-1","journal-title":"BMC Nephrol"},{"key":"4987_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/14740338.2019.1594771","volume":"18","author":"L Strilchuk","year":"2019","unstructured":"Strilchuk L, Fogacci F, Cicero AF (2019) Safety and tolerability of available urate-lowering drugs: a critical review. Expert Opin Drug Saf 18:261\u2013271. https:\/\/doi.org\/10.1080\/14740338.2019.1594771","journal-title":"Expert Opin Drug Saf"},{"key":"4987_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26189000","volume":"26","author":"T Takata","year":"2025","unstructured":"Takata T, Mae Y, Hoi S, Iyama T, Isomoto H (2025) Hyperuricemia in chronic kidney disease: emerging pathophysiology and a novel therapeutic strategy. Int J Mol Sci 26:9000. https:\/\/doi.org\/10.3390\/ijms26189000","journal-title":"Int J Mol Sci"},{"key":"4987_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/09553002.2018.1420926","volume":"94","author":"F Talebpour Amiri","year":"2018","unstructured":"Talebpour Amiri F, Hamzeh M, Naeimi RA, Ghasemi A, Hosseinimehr SJ (2018) Radioprotective effect of atorvastatin against ionizing radiation-induced nephrotoxicity in mice. Int J Radiat Biol 94:106\u2013113. https:\/\/doi.org\/10.1080\/09553002.2018.1420926","journal-title":"Int J Radiat Biol"},{"key":"4987_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/nep.14420","volume":"30","author":"R Talukdar","year":"2025","unstructured":"Talukdar R, Ajayan R, Gupta S, Biswas S, Parveen M, Sadhukhan D (2025) Chronic kidney disease prevalence in India: a systematic review and meta-analysis from community-based representative evidence between 2011 to 2023. Nephrology 30:e14420. https:\/\/doi.org\/10.1111\/nep.14420","journal-title":"Nephrology"},{"issue":"2","key":"4987_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.23876\/j.krcp.20.163","volume":"40","author":"S Verma","year":"2021","unstructured":"Verma S, Singh P, Khurana S, Ganguly NK, Kukreti R, Saso L, Rana DS, Taneja V, Bhargava V (2021) Implications of oxidative stress in chronic kidney disease: current concepts and therapies. Kidney Res Clin Pract 40(2):183\u2013193. https:\/\/doi.org\/10.23876\/j.krcp.20.163","journal-title":"Kidney Res Clin Pract"},{"issue":"2","key":"4987_CR40","doi-asserted-by":"publisher","DOI":"10.23876\/j.krcp.20.163","volume":"40","author":"S Verma","year":"2021","unstructured":"Verma S, Singh P, Khurana S, Ganguly NK, Kukreti R, Saso L, Rana DS, Taneja V, Bhargava V (2021) Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies. Kidney Res Clin Pract 40(2):183. https:\/\/doi.org\/10.23876\/j.krcp.20.163","journal-title":"Kidney Res Clin Pract"},{"key":"4987_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13040455","volume":"13","author":"N Wang","year":"2024","unstructured":"Wang N, Zhang C (2024) Oxidative stress: a culprit in the progression of diabetic kidney disease. Antioxidants 13:455. https:\/\/doi.org\/10.3390\/antiox13040455","journal-title":"Antioxidants"},{"key":"4987_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejphar.2014.11.035","volume":"747","author":"MX Wang","year":"2015","unstructured":"Wang MX, Liu YL, Yang Y, Zhang DM, Kong LD (2015) Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice. Eur J Pharmacol 747:59\u201370. https:\/\/doi.org\/10.1016\/j.ejphar.2014.11.035","journal-title":"Eur J Pharmacol"},{"key":"4987_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32006-z","volume":"8","author":"N Wang","year":"2018","unstructured":"Wang N, Li P, Pan J, Wang M, Long M, Zang J, Yang S (2018) Bacillus velezensis A2 fermentation exerts a protective effect on renal injury induced by zearalenone in mice. Sci Rep 8:13646. https:\/\/doi.org\/10.1038\/s41598-018-32006-z","journal-title":"Sci Rep"},{"key":"4987_CR44","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1161\/01.atv.19.5.1168","volume":"19","author":"R Wever","year":"1999","unstructured":"Wever R, Boer P, Hijmering M, Stroes E, Verhaar M, Kastelein J, Versluis K, Lagerwerf F, van Rijn H, Koomans H, Rabelink T (1999) Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 19:1168\u20131172. https:\/\/doi.org\/10.1161\/01.atv.19.5.1168","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4987_CR45","unstructured":"WHO (2025) Reducing the burden of noncommunicable diseases through promotion of kidney health and strengthening prevention and control of kidney disease.\u00a0https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/EB156\/B156_CONF6-en.pdf"},{"key":"4987_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.120110","volume":"567","author":"Q Wu","year":"2025","unstructured":"Wu Q, Gao Y, Zhang X, Cui W, Li S, Luo C, Mo D, Cheng X (2025) A case of transient elevation of creatinine caused by severe hyperuricemia. Clin Chim Acta 567:120110. https:\/\/doi.org\/10.1016\/j.cca.2024.120110","journal-title":"Clin Chim Acta"},{"key":"4987_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2021.129067","volume":"348","author":"Z Xie","year":"2021","unstructured":"Xie Z, Cao N, Wang C (2021) A review on \u03b2-carboline alkaloids and their distribution in foodstuffs: a class of potential functional components or not? Food Chem 348:129067. https:\/\/doi.org\/10.1016\/j.foodchem.2021.129067","journal-title":"Food Chem"},{"key":"4987_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1026246","volume":"13","author":"B Yang","year":"2022","unstructured":"Yang B, Xin M, Liang S, Xu X, Cai T, Dong L, Wang C, Wang M, Cui Y, Song X, Sun J (2022) New insight into the management of renal excretion and hyperuricemia: potential therapeutic strategies with natural bioactive compounds. Front Pharmacol 13:1026246. https:\/\/doi.org\/10.3389\/fphar.2022.1026246","journal-title":"Front Pharmacol"},{"key":"4987_CR49","doi-asserted-by":"publisher","unstructured":"Zhan X, Do LV, Zou L, Zhan RS, Jones M, Nawaz S, Manaye K (2023) Harmaline toxicity on dorsal striatal neurons and its role in tremor. Neurotoxicology 99:152-161. https:\/\/doi.org\/10.1016\/j.neuro.2023.10.005","DOI":"10.1016\/j.neuro.2023.10.005"},{"key":"4987_CR50","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5847\/wjem.j.issn.1920-8642.2012.03.005","volume":"3","author":"HC Zhu","year":"2012","unstructured":"Zhu HC, Cao RL (2012) The relationship between serum levels of uric acid and prognosis of infection in critically ill patients. World J Emerg Med 3:186\u2013190. https:\/\/doi.org\/10.5847\/wjem.j.issn.1920-8642.2012.03.005","journal-title":"World J Emerg Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-04987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-04987-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-04987-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T02:43:26Z","timestamp":1778208206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-04987-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4987"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-04987-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study received approval from the Institutional Animal Ethics Committee (Protocol No. CU\/2025\/IAEC\/11\/01) and was conducted following the ethical guidelines established by the Ministry of Environment and Forests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}